SOHO Italy 2022 | New frontiers in overcoming environment-mediated drug resistance in AML
In this video, Claudio Cerchione, MD, PhD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, shares some insights into the importance of better understanding environment-mediated drug resistance in acute myeloid leukemia (AML). Dr Cerchione comments on the role of E-selectin as a novel target in relapsed/refractory (R/R) disease, and further discusses the potential use of uproleselan, a novel E-selectin antagonist, being explored in this space. This interview took place at The 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
